Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01713686 · ClinicalTrials.gov registry record · NA
Evaluation of the Ulthera System for the Treatment of the Decolletage
A NA study of Chest Wrinkles, sponsored by Ulthera.
- Completed
- Registry status
- NA
- Development phase
- 129
- Enrollment target
- 4
- Study locations
NCT01713686 is a NA study of Chest Wrinkles that has completed, run by Ulthera. The registered enrollment target is 129 participants. The trial reports 4 study locations across 3 states.
The verdict
NCT01713686, a NA study of Chest Wrinkles, has completed, sponsored by Ulthera.
- COMPLETED
- Registry status
- NA
- Development phase
- 129 participants
- Enrollment target
- 4
- Study locations
Study Summary
This is prospective, multi-center clinical trial. Enrolled subjects will receive one Ulthera® treatment on the decolletage. Follow-up visits will occur at 90 and 180 days following treatment. Study images will be obtained pre-treatment, immediately post-treatment, and at each follow-up visit.
Conditions Studied
Interventions
- DEVICE Ulthera System Treatment
Study Locations (4)
California
- Laser Skin and Surgery Center of Northern California - Sacramento
- Dermatology Cosmetic Laser Medical Associates of La Jolla, Inc. - San Diego
Illinois
- Denova Research - Chicago
Tennessee
- Tennessee Research Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2012-10 |
| Est. Completion | 2013-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01713686
The ClinicalTrials.gov registry entry for NCT01713686 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ulthera, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chest Wrinkles appearing as the primary indexed condition, and to 1 intervention - of which Ulthera System Treatment is the first listed.
NCT01713686 reports 4 study locations spanning 3 distinct geographic areas - top geographies include California, Illinois, Tennessee.
Frequently Asked Questions
What is clinical trial NCT01713686 about?
NCT01713686 is a clinical study titled "Evaluation of the Ulthera System for the Treatment of the Decolletage". This is prospective, multi-center clinical trial. Enrolled subjects will receive one Ulthera® treatment on the decolletage. Follow-up visits will occur at 90 and 180 days following treatment. Study images will be obtained pre-treatment, immediately post-treatment, and at each follow-up visit.
What is the current status of trial NCT01713686?
This trial is currently completed. It is a NA study. The enrollment target is 129 participants. The study started on 2012-10. Estimated completion is 2013-08.
What conditions does trial NCT01713686 study?
This clinical trial studies the following conditions: Chest Wrinkles.
What interventions are being tested in trial NCT01713686?
The interventions under investigation include: Ulthera System Treatment (DEVICE).
Who is sponsoring clinical trial NCT01713686?
This trial is sponsored by Ulthera, which has 42 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01713686 being conducted?
This trial has 4 study locations across California, Illinois, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.